Assessing the Chiral Switch: Approval and Use of Single-Enantiomer Drugs, 2001 to 2011
From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.
